Schreiner, Philipp, Harrer, Thomas, Scheibenbogen, Carmen et al. · ImmunoHorizons · 2020 · DOI
This study explores how a virus called HHV-6 might trigger ME/CFS by examining what happens inside cells when the virus reactivates. The researchers found that when HHV-6 wakes up, it causes cells to switch into a protective mode that fights other viruses but seriously damages the cell's power plants (mitochondria) and energy-making abilities. Importantly, blood serum from ME/CFS patients showed similar patterns, suggesting HHV-6 reactivation may play a role in the disease.
This research provides a potential mechanistic link between HHV-6 reactivation and ME/CFS pathology, specifically explaining how the infection might trigger the characteristic combination of antiviral activation and energy metabolism failure seen in patients. Understanding this mechanism could lead to targeted therapeutic interventions and better diagnostic approaches for ME/CFS.
This study does not prove that HHV-6 reactivation causes ME/CFS in all patients, as correlation and laboratory findings do not establish causation in the complex multifactorial disease. The work does not explain why some individuals with HHV-6 reactivation develop ME/CFS while others do not, nor does it exclude other triggers. Additionally, cell culture findings may not fully translate to the complex human immune and metabolic environment.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.